Kristine E. Burgess
Assistant Professor
Department of Clinical Sciences
Oncology
Phone: 508-839-5395 ext. 84251
Fax: 508-839-7922 or 7951
Email: kristine.burgess@tufts.edu

Education

DVM - Tufts University - 1997
MS - Harvard University - 1991
BS - University of Massachusetts - 1988

Board Certification

American College of Veterinary Internal Medicine - Oncology

General Research and Clinical Interest

• Understanding the molecular mechanisms that trigger the development of canine/feline cancer and applying those findings into improved diagnostic capabilities and therapeutic options for treatment 
• Participating in clinical trials that evaluate the use of novel chemotherapeutics and immunotherapies in various malignancies 

Research Sponsor Interest

• Privately Funded Research
• Federally Funded Research

Selected Publications

1. Frantz AM, Sarver AL, Ito D, Phang TL, Karimpour-Fard A, Scott, MC, Valli VEO, Lindblad-Toh K, Burgess KE, Husbands BD, Henson MS, Borgatti A, Kisseberth WC, Hunter LE, Breen M, O'Brien T and Modiano, JF (2012). Molecular Profiling reveals prognostically significant subtypes of canine lymphoma Vet Path accepted for publication.
2. Burgess KE, Mayer J (2012). A proposal for a standardized classification of ferret lymphoma Journal of Exotic Pet Medicine accepted for publication.
3. Tsai S, Sutherland-Smith J, Burgess KE, Ruthazer R, Sato A (2011). Imaging Characteristics of Intrathoracic Histiocytic Sarcoma in Dogs Veterinary Radiology and Ultrasound 53 (1): 21-27
4. Ito D, Endicott M, Jubala C, Burgess KE, et al. (2011). A Tumor Related Lymphoid Progenitor Population Supports Hierarchical Tumor Organization in Canine B Cell Lymphoma. Journal of Veterinary Internal Medicine 25:890-896
5. Thomas R, Seiser EL, Motsinger-Reif A, Borst L, Valli VE, Kelley K, Suter SE, Argyle D, Burgess KE, Bell J, Lindblad-Toh K, Modiano JF, Breen M (2011). Refining tumor-associated aneuploidy through "genomic recording" of recurrent DNA copy number aberrrations in 150 canine non-Hodgkin lymphomas. Leukemia and Lymphoma Early Online Edition March 2011
6. Rau, SE, Barber, LG, Burgess, KE (2010). Efficacy of maropitant (CereniaTM) in the prevention of delayed vomiting associated with doxorubicin administration. Journal of Veterinary Internal Medicine 24(6): 1452-1457.
7. Burgess, KE, Wood, DR, Green, EM, Dubielzig RR (2010). Nasal Angiofibroma in 13 Dogs. Veterinary Comparative Oncology vol 9 (4):304-309.
8. DeRegis CJ, Keating, JH, Burgess KE (2010). Review of immunohistochemistry and proliferation indices for diagnosis of canine caner. Veterinary Comparative Oncology, Submitted
9. Burr, H, Keating, JH, Burgess, KE (2010). Feline Tarsal Lymphoma: A Retrospective, Multi-Institutional Study. JAVMA in preparation
10. M. Gauthier, L.G. Barber, K.E. Burgess (2009). Identifying and Treating Anal Sac Adenocarcinoma in the Dog. Veterinary Medicine 104 (2): 74-81.
11. Rau, SE and Burgess, KE (2008). PRL-3 Expression in Metastatic Cancers. Veterinary Cancer Society Newsletter.